Results 301 to 310 of about 1,109,815 (338)

Editorial: Artificial intelligence: new hope for critically ill cardiovascular patients

open access: yesFrontiers in Medicine
Li-li Wu   +7 more
doaj   +1 more source

Nanotechnology in cardiovascular medicine [PDF]

open access: possibleCatheterization and Cardiovascular Interventions, 2007
AbstractNanotechnology is a new field of science and technology that has already had significant impact in the development of novel products in industry. In medicine, application of nanotechnology has the potential to develop new imaging agents, pharmaceutical drugs and medical devices with unique physical and chemical properties.
Steven R. Bailey, Devang N. Patel
openaire   +2 more sources

Trimetazidine in cardiovascular medicine

International Journal of Cardiology, 2019
Abnormalities of myocardial energy metabolism appear as a common background of the two major cardiac disorders: ischemic heart disease (IHD) and heart failure (HF). Myocardial ischemia has been recently conceived as a multifaceted syndrome that can be precipitated by a number of mechanisms including metabolic abnormalities. HF is a progressive disorder
Marzilli M.   +15 more
openaire   +4 more sources

Rapamycin in cardiovascular medicine

Internal Medicine Journal, 2003
Abstract The cellular action of rapamycin (sirolimus), a natural fermentation product produced by Strepto­myces hygroscopicus, is mediated by binding to the FK506 binding protein. By inhibiting a kinase known as the target of rapamycin, it restricts the proliferation of smooth‐muscle cells by blocking cell‐cycle progression at the G1/S transition.The ...
Danièle Muller   +2 more
openaire   +4 more sources

Cardiovascular medicine: a year in review

Minerva Cardiology and Angiology, 2022
Cardiovascular medicine is facing several challenges in the current era, dominated by the rapid spread of a previously unknown virus around the world. Indeed, the 2020 COVID-19 pandemic set the course of cardiovascular science and education in an extraordinary way, hogging the attention of the medical community.
Matteucci, Andrea   +7 more
openaire   +5 more sources

Colchicine for Cardiovascular Medicine

Future Cardiology, 2015
Colchicine is an ancient drug with anti-inflammatory effects especially on neutrophils. These cells are critically involved in pericardial and atherosclerotic plaques inflammation, thus representing a new potential target for new therapies to treat and especially prevent cardiovascular events such as pericarditis, atrial fibrillation triggered by ...
Massimo Imazio, Fiorenzo Gaita
openaire   +3 more sources

Biomarkers in Cardiovascular Medicine

Revista Española de Cardiología (English Edition), 2009
Cardiovascular disease is the principal cause of death in developed countries. The underlying pathological process is arterial wall thickening due to the formation of atherosclerotic plaque, which is frequently complicated by thrombus, thereby giving rise to the possibility of acute coronary syndrome or stroke.
Begoña Muñoz-García   +7 more
openaire   +3 more sources

Cardiovascular nuclear medicine

Seminars in Nuclear Medicine, 1977
Exciting developments in radiopharmaceuticals and instrumentation have established the field of cardiovascular nuclear medicine as an extremely useful clinical tool. Depending on the patient's problem, one may elect to perform myocardial perfusion images with 201Tl, infarct avid images with 99m Tc, or wall motion and other functional studies with ...
B, Pitt, H W, Strauss
openaire   +2 more sources

Photonics in cardiovascular medicine

Nature Photonics, 2015
The use of photonics technology is bringing new capabilities and insights to cardiovascular medicine. Intracoronary imaging and sensing, laser ablation and optical pacing are just some of the functions being explored to help diagnose and treat conditions of the heart and arteries.
Evelyn Regar   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy